Papers

2

Total Citations

10

H-Index

2

About

Dr. Gyoohwan Jung is a urologic surgeon and researcher whose work bridges cutting-edge surgical innovation with rigorous clinical evidence. His primary research focuses on optimizing treatment outcomes for localized prostate cancer, particularly through comparative effectiveness studies of emerging technologies. In a landmark 2022 study, Dr. Jung led a large-scale, propensity score-matched analysis of over 3,800 patients, directly comparing partial gland ablation using high-intensity focused ultrasound (HIFU) against robot-assisted radical prostatectomy (RARP). This work, which has garnered significant attention, provides crucial data for shared decision-making, demonstrating his commitment to less invasive, organ-sparing approaches. Beyond oncology, Dr. Jung is advancing surgical wound care. He conducted a randomized controlled trial evaluating the Xkin closure device—a novel zipper-type adhesive tape—against traditional staplers. His findings on wound healing and complication rates offer practical insights for improving patient recovery. With a growing citation footprint, Dr. Jung’s contributions are shaping both the technical execution and the evidence base of modern urologic surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Partial gland ablation using high-intensity focused ultrasound versus robot-assisted radical prostatectomy: a propensity score-matched study
7 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Seoul National University Bundang Hospital, Hanyang University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago